Silver Book Fact

Multifoca electroretinogram (mFERG) measures show abnormal function of the retina early in–and even prior to–diabetic retinopathy onset and could enhance monitoring of the early stages of disease progression in individuals.

Bearse M, Adams A, Han Y, Schneck M, et al. A Mulifocal Electroretinogram Model Predicting the Development of Diabetic Retinopathy. Prog Retin Eye Res. 2006; 25(5): 425-448. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2773701/

Reference

Title
A Mulifocal Electroretinogram Model Predicting the Development of Diabetic Retinopathy
Publication
Prog Retin Eye Res
Publication Date
2006
Authors
Bearse M, Adams A, Han Y, Schneck M, et al
Volume & Issue
Volume 25, Issue 5
Pages
425-448
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Screening and treatment of diabetic retinopathy in type 2 diabetes patients produces annual savings of $247.9 million to the federal budget– in 1994 dollars.  
  • The cost-effectiveness of detection and treatment of eye disease in diabetics is $3,190 per quality adjusted life year (QALY).  
  • High-intensity ultrasonic cyclocoagulation reduces intraocular pressure in refractory glaucoma patients.  
  • Of the 8 million older Americans at high risk of developing advanced age-related macular degeneration (AMD), 1.3 million will develop advanced AMD within 5 years. However, the NEI-sponsored Age-Related Eye…  
  • Anti-VEGF Letter Improvement
    An anti-VEGF therapy for DME improved vision by more than 15 letters in approximately 36-51% of participants in a trial.